CA2188871C - Methode pour le traitement du psoriasis - Google Patents

Methode pour le traitement du psoriasis Download PDF

Info

Publication number
CA2188871C
CA2188871C CA002188871A CA2188871A CA2188871C CA 2188871 C CA2188871 C CA 2188871C CA 002188871 A CA002188871 A CA 002188871A CA 2188871 A CA2188871 A CA 2188871A CA 2188871 C CA2188871 C CA 2188871C
Authority
CA
Canada
Prior art keywords
interleukin
use according
psoriasis
units
body weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002188871A
Other languages
English (en)
Other versions
CA2188871A1 (fr
Inventor
Robert I. Abels
Karen Reilly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CA2188871A1 publication Critical patent/CA2188871A1/fr
Application granted granted Critical
Publication of CA2188871C publication Critical patent/CA2188871C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne un procédé thérapeutique permettant de traiter un être humain souffrant de psoriasis et qui consiste à administrer au sujet une quantité efficace d'IL-2 inhibant une dermatose psoriasique, et un excipient pharmaceutiquement acceptable.
CA002188871A 1993-09-21 1993-09-21 Methode pour le traitement du psoriasis Expired - Fee Related CA2188871C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/008953 WO1995008340A1 (fr) 1993-09-21 1993-09-21 Procede de traitement du psoriasis

Publications (2)

Publication Number Publication Date
CA2188871A1 CA2188871A1 (fr) 1995-03-30
CA2188871C true CA2188871C (fr) 2001-01-23

Family

ID=22236983

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002188871A Expired - Fee Related CA2188871C (fr) 1993-09-21 1993-09-21 Methode pour le traitement du psoriasis

Country Status (3)

Country Link
AU (1) AU5134693A (fr)
CA (1) CA2188871C (fr)
WO (1) WO1995008340A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103536905A (zh) * 2013-10-28 2014-01-29 中国医学科学院基础医学研究所 白介素-2在制备银屑病药物中的应用
CN113234138A (zh) 2014-08-11 2021-08-10 德里尼亚公司 选择性地活化调节性t细胞用于治疗自身免疫病的修饰的il-2变体
US20170204154A1 (en) 2016-01-20 2017-07-20 Delinia, Inc. Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases
AU2017359172A1 (en) 2016-11-08 2019-05-16 Delinia, Inc. IL-2 variants for the treatment of autoimmune diseases

Also Published As

Publication number Publication date
AU5134693A (en) 1995-04-10
WO1995008340A1 (fr) 1995-03-30
CA2188871A1 (fr) 1995-03-30

Similar Documents

Publication Publication Date Title
Lee et al. Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study.
US5128126A (en) Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions
US5449522A (en) Pharmaceutical composition for immunoenhancement therapy
US6143717A (en) Pharmaceutical composition and method for immunoenhancement therapy
CN1094642A (zh) 治疗组合物
AU661979B2 (en) Use of IL-4 to treat solid tumors
US5582822A (en) Treatment of leukemia using interleukin 2
US5466447A (en) Method for treating psoriasis
CN100536910C (zh) 胸腺素α1肽/聚合物结合物
EP0382381B1 (fr) Traitement des désordres leucocytaires par le GM-CSF
EP0225759B1 (fr) Compositions d'interféron
CA2188871C (fr) Methode pour le traitement du psoriasis
Larionov Some biological and clinical results from the investigations of the chloroethylamines as anti-tumour drugs
JP3266248B2 (ja) 傷害を処置するための方法及び組成物
JP2784401B2 (ja) 慢性骨髄性白血病の治療方法
CN1582163A (zh) 胸腺素α1肽的给药方法
Bui et al. Differential disposition of soluble and liposome-formulated human recombinant interleukin-7: effects on blood lymphocyte population in guinea pigs
Barbaro et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on HIV-related leukopenia: a randomized, controlled clinical study
JP2008031179A (ja) β−インターフェロンを使用して再狭窄を治療する方法
CA2638985C (fr) Agent therapeutique contenant de l'interferon .omega. felin pour le traitement de la dermatite atopique feline
EP0377823A2 (fr) Utilisation de TNF pour l'obtention d'un médicament destiné au traitement du psoriasis
Nakano et al. Accelerated recovery of antigen-presenting cell activity by the administration of interleukin 1α in 5-fluorouracil-treated mice
JPH0618780B2 (ja) 骨髄性白血病抑制剤
KR20010032511A (ko) 조혈 간세포를 이동시키는 방법
Ikemoto et al. Multiple pulmonary metastases from renal cell carcinoma treated effectively by recombinant interleukin-2

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed